Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia

BACKGROUND: The incidence of opioid-related overdose deaths has been rising for 30 years and has been further exacerbated amidst the COVID-19 pandemic. Naloxone can reverse opioid overdose, lower death rates, and enable a transition to medication for opioid use disorder. Though current formulations...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanter, Katie, Gallagher, Ryan, Eweje, Feyisope, Lee, Alexander, Gordon, David, Landy, Stephen, Gasior, Julia, Soto-Calderon, Haideliza, Cronholm, Peter F., Cocchiaro, Ben, Weimer, James, Roth, Alexis, Lankenau, Stephen, Brenner, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299455/
https://www.ncbi.nlm.nih.gov/pubmed/34301246
http://dx.doi.org/10.1186/s12954-021-00522-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299455/
https://www.ncbi.nlm.nih.gov/pubmed/34301246
http://dx.doi.org/10.1186/s12954-021-00522-3

Ejemplares similares